Inhibitor Therapeutics, Inc. Proceeds from Related Party Debt
Inhibitor Therapeutics, Inc. (INTI) reported Proceeds from Related Party Debt of $180.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2023-11-13
- Inhibitor Therapeutics, Inc. proceeds from related party debt for the quarter ending 2022-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for the quarter ending 2022-09-30 was $80.00K.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for the quarter ending 2022-06-30 was $50.00K, a 33.33% decline year-over-year.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for the quarter ending 2022-03-31 was $50.00K, a 50.50% decline year-over-year.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for fiscal 2022 was $180.00K, a 2.27% increase from fiscal 2021.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for fiscal 2021 was $176.00K, a 220.00% increase from fiscal 2020.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for fiscal 2020 was $55.00K.
- Inhibitor Therapeutics, Inc. proceeds from related party debt for fiscal 2019 was $0.00.
| Period end | Proceeds from Related Party Debt | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $80.00K derived: sum of 2 quarters · filed 2023-11-13 | $130.00K derived: sum of 3 quarters · filed 2023-11-13 | $180.00K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $130.00K derived: sum of 2 quarters · filed 2023-11-13 | $180.00K 10-Q · filed 2023-11-13 | $180.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $100.00K 10-Q · filed 2023-08-11 | $100.00K derived: sum of 3 quarters · filed 2023-08-11 | $100.00K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-15 | $50.00K derived: sum of 2 quarters · filed 2023-05-15 | $50.00K derived: sum of 3 quarters · filed 2023-05-15 | $125.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-03-09 | $281.00K 10-Q · filed 2022-11-14 | ||||
| 2022-01-13 | $231.00K 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $75.00K derived: sum of 3 quarters · filed 2023-03-31 | $176.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $75.00K derived: sum of 2 quarters · filed 2021-11-12 | $176.00K 10-Q · filed 2021-11-12 | $231.00K derived: sum of 4 quarters · filed 2022-03-30 | |
| 2021-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $176.00K 10-Q · filed 2021-08-13 | $231.00K derived: sum of 3 quarters · filed 2022-03-30 | $231.00K derived: sum of 4 quarters · filed 2022-03-30 | |
| 2021-03-31 | $101.00K 10-Q · filed 2021-05-14 | $156.00K derived: sum of 2 quarters · filed 2022-03-30 | $156.00K derived: sum of 3 quarters · filed 2022-03-30 | $156.00K derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $55.00K derived: sum of 2 quarters · filed 2022-03-30 | $55.00K derived: sum of 3 quarters · filed 2022-03-30 | $55.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-26 |